A new class of high-power, three-phase AC-DC units with flexible outputs and industrial temp resilience aims to streamline power design in test, fab and manufacturing systems.

TDK has announced the release of the TDK‑Lambda TPS4500 series of industrial AC‑DC power supplies, offering a rated output of ...

A stable "exceptional fermionic superfluid," a new quantum phase that intrinsically hosts singularities known as exceptional ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the ...

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

Preliminary shotgun metagenomic sequencing demonstrated that EBX-102-02 induced a broad and sustained shift in the gut ...

Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

There is a time in the crypto cycle when the market is no longer willing to reward already big coins, and begins to pursue the next one. This tends to occur ...

Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been ...